泪腺腺样囊性癌保留眼球手术联合质子束放疗的长期结局
3例成人死于转移,4例局部复发,有用视力(20/40或更好)中位保留3年,总生存与无病生存优于历史治疗但与现代其他方法无统计学差异。
要点
- 保留眼球手术联合质子束放疗可获得较好长期生存。
- 有用视力中位保留3年,放疗可致脑损伤、视网膜病变等并发症。
- 局部复发4例,3例成人死于转移。
核心结论
- 保留眼球手术联合质子束放疗虽不完美,但长期生存优于历史治疗,并提供可变时长的有用视力。
主要发现
- 3例成人死于转移(治疗后中位4.2年),4例局部复发。
- 有用视力(20/40或更好)中位保留3年(范围1-12.9年)。
- 放疗并发症包括脑损伤、视网膜病变、视神经病变、角膜病变和白内障。
- 总生存和无病生存显著优于历史治疗,但与现代其他方法无统计学差异。
关键数值与推荐
- 所有患者接受保留眼球肿瘤切除联合放疗,中位剂量72钴灰当量。
临床怎么用
- 对于原发泪腺腺样囊性癌,可考虑保留眼球手术联合质子束放疗以维持长期生存和可变时长的有用视力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe outcomes of globe-preserving surgery combined with high-dose proton beam radiation (PBR) in treating primary adenoid cystic carcinoma (ACC) of the lacrimal gland. DESIGN: Retrospective case series. METHODS: Twenty-nine patients with primary ACC of the lacrimal gland were identified in the records of a single institution between 1990 and 2017. Patients with nonorbital primary tumor origins or with inadequate follow-ups were excluded. Eighteen patients met inclusion criteria. Clinical data, imaging studies, histopathology, treatment modality, local recurrences, visual outcomes, metastases, and survivals were assessed. Disease-free survivals for the current patients were measured and compared to those of other studies. RESULTS: The eighteen patients (14 female, 4 male) were followed for a median of 12.9 years (range 0.6-22.3 years) after treatment completion. Their median age was 40 years. Four were children (median age 12 years). All were treated with globe-preserving tumor resection and radiation (median dose of 72 cobalt gray equivalents). Three adult patients died of metastatic disease (median of 4.2 years after treatment). Four had local recurrences. Useful vision (20/40 or better) was retained for a median 3 years (range 1-12.9 years). Radiation morbidity included brain injury, retinopathy, optic neuropathy, keratopathy, and cataract. Overall and disease-free survivals were significantly better compared to historical treatments, but did not differ statistically from other modern approaches. CONCLUSIONS: Globe-preserving surgery with PBR, although imperfect, has a favorable long-term survival compared to other modern modalities, and offers a variable period of useful vision.
引用
- Wolkow N, Jakobiec FA, Lee H, et al. Long-term Outcomes of Globe-Preserving Surgery With Proton Beam Radiation for Adenoid Cystic Carcinoma of the Lacrimal Gland. Am J Ophthalmol. 2018. PMID: 30071211. doi:10.1016/j.ajo.2018.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。